4//SEC Filing
MACK DAVID J. 4
Accession 0001104659-25-009204
CIK 0001720893other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:28 PM ET
Size
7.2 KB
Accession
0001104659-25-009204
Insider Transaction Report
Form 4
MACK DAVID J.
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-01-31−27,089→ 243,810 total→ Common Stock (27,089 underlying) - Exercise/Conversion
Common Stock
2025-01-31+27,089→ 81,267 total
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001694466
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:28 PM ET
- Size
- 7.2 KB